SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Pitman Elizabeth N (Last) (First) (Middle) 1901 SIXTH AVE NORTH SUITE 1400 (Street) BIRMINGHAM AL 35203 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol MEDICAL PROPERTIES TRUST INC [ MPW ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 06/02/2023
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person
	Rule 10b5-1(c) Transaction Indication Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	06/02/2023		A		1,780	A	$8.42	48,764	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Matthew W. Stuenkel, by power of attorney	06/02/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS

I hereby constitute and appoint W. Zachary Riddle, Matthew W. Stuenkel,
Armstead L. Hayes IV, and Clayton C. Porter, each an employee of Medical
Properties Trust, Inc. (the 'Company') or certain of its subsidiaries,
as my true and lawful attorney-in-fact to undertake the following activities,
acting individually and not collectively:

1.	prepare, execute in my name and on my behalf, and submit to the Securities
	and Exchange Commission (the 'SEC') a Form ID, including amendments thereto,
	and any other documents necessary or appropriate to obtain codes and passwords
	enabling me to make electronic filings with the SEC of reports required by
	Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation
	of the SEC.

2.	execute, for and on my behalf, in my capacity as an officer and/or director
	of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the
	Securities Exchange Act of 1934 and the related rules, and any other forms
	or reports I may be required to file in connection with my ownership,
	acquisition, or disposition of securities of the Company;

3.	perform any acts on my behalf which may be necessary or desirable to complete
	and execute any such Form 3, 4 or 5, or other form or report, and to file such
	forms or reports with the SEC and any stock exchange or similar authority; and

4.	take any other action in connection with the foregoing which, in the opinion
	of such attorney-in-fact, may be of benefit to, in the best interest of, or
	legally required by me, it being understood that the documents executed by
	such attorney-in-fact on my behalf pursuant to this power of attorney shall
	be in such form and contain such terms and conditions as such
	attorney-in-fact may approve in such attorney-in-fact's discretion.

I hereby grant to each such attorney-in-fact full power and authority to perform
any act necessary or proper to be done in the exercise of any of the rights and
powers granted in this power of attorney, as fully as I could do if personally
present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorneys-in-fact, or their substitutes, lawfully do or
cause to be done by virtue of this power of attorney and the rights and powers
granted in this power of attorney. I acknowledge that the foregoing
attorneys-in-fact, in serving in such capacity at my request, are not assuming,
nor is the Company assuming, any of my responsibilities to comply with
Section 16 of the Securities and Exchange Act of 1934.

This limited power of attorney shall be effective on the date set forth below
and shall remain in full force and effect until I am no longer required to
file Forms 3, 4 and 5 with respect to my holdings of and transactions in
the Company's securities, unless I revoke it earlier in a signed writing
filed with the SEC or delivered to the foregoing attorneys-in-fact.

Any previous powers of attorney granted to any other parties for the limited
purposes described above herein are deemed revoked and have no further force
and effect.

IN WITNESS WHEREOF, I have executed this power of attorney this
16th day of February, 2023.

/s/ Elizabeth N. Pitman
_________________________________________________________
Elizabeth N. Pitman

0EXHIBIT 24 POWER OF ATTORNEY